Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10167292
Benzodiazepines as bromodomain inhibitors
granted -
US 10166216
Substituted triazoles useful as Axl inhibitors
granted -
US 10160753
Indazole compounds as IRAK4 inhibitors
granted -
US 10160760
Compounds useful as inhibitors of ATR kinase
granted -
US 10155789
Substrates and inhibitors of prolyl oligopeptidase and methods of use thereof
granted -
US 10150783
Heterocyclic ITK inhibitors for treating inflammation and cancer
granted -
US 10144930
Inhibitors of MYH7B and uses thereof
granted -
US 10137100
Administration of serine protease inhibitors to the stomach
granted -
US 10138486
Inhibitors of DEK protein and related methods
granted -
US 10137121
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 10138255
Piperazine derivatives as HIV protease inhibitors
granted -
US 10130642
Neprilysin inhibitors
granted -
US 10130618
Pharmaceutical combinations of dabigatran and proton pump inhibitors
granted -
US 10130623
Tyrosine kinase inhibitors
granted -
US 10131659
Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof
granted -
US 10125131
Selective HDAC3 inhibitors
granted -
US 10125128
GLS1 inhibitors for treating disease
granted -
US 10123984
Neprilysin inhibitors
granted -
US 10125102
Human plasma kallikrein inhibitors
granted -
US 10125134
KRas G12C inhibitors
granted -
US 10117945
mTORC1 inhibitors
granted -
US 10117871
3-hydroxypyrimidine-2,4-dione-5-carboxamides as potent inhibitors of HIV
granted -
US 10111878
N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer
granted -
US 10106540
HDAC6 inhibitors and their uses
granted